View of OPTIMIZATION OF BIOEQUIVALENCE PROGRAMS AND PHARMACOECONOMIC DECISION-MAKING FOR GENERIC METFORMIN HYDROCHLORIDE IMMEDIATE-RELEASE TABLETS: A REGULATORY BIOPHARMACEUTICS FRAMEWORK

Return to Article Details OPTIMIZATION OF BIOEQUIVALENCE PROGRAMS AND PHARMACOECONOMIC DECISION-MAKING FOR GENERIC METFORMIN HYDROCHLORIDE IMMEDIATE-RELEASE TABLETS: A REGULATORY BIOPHARMACEUTICS FRAMEWORK Download Download PDF